Christopher Michael Cashman

This profile gathers the share dealings of Christopher Michael Cashman in Marinus Pharmaceuticals, Inc. Over a trading history stretching from 6 November 2015 to 9 February 2016, the count stands at 2 filings.

Every open-market trade on record is a purchase: 1 purchase, and no sale. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 option exercise. Since January 2016: 1 purchase and no sales on the market.

The record was last updated on 11 February 2016 with an option exercise in Marinus Pharmaceuticals, Inc. The clock since the last published purchase (11 February 2016) now reads 3,902 days. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.